Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
News Menu

News

Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)

Newswire.ca - Press Release

All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
Add as a preferred source on Google Add as a preferred source on Google

SINGAPORE, June 3, 2025 /CNW/ -- The Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and development, has announced the presentation of updated clinical data for the ongoing Phase 1 trial for EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

Read more at newswire.ca

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

Most Popular News

Oracle Corp_ logo on phone and stock data-by Rokas Tenys via Shutterstock 1
Oracle Stock Plunges 55%: Buy the Dip or Stay Away?
Palantir by rblfmr via Shutterstock 2
If Palantir is Near a Bottom, What's the Best Play in PLTR Stock?
Fearless girl in front of bull on Wall Street by Daniel Lloyd Blunk-Fernandez via Unsplash 3
Most Retail Investors Think They’re Investing: They’re Actually Trading The Market
Phone and computer internet network by Pinkypills via iStock 4
Dear IonQ Stock Fans, Mark Your Calendars for February 25
A Palantir sign displayed on an office building by Poetra_RH via Shutterstock 5
Down 24% in 2026, Where Is Palantir Stock Headed Next and Should You Buy PLTR Here?
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot